Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV reports results for the quarter ended in June - Earnings Summary
Brief: Pharvaris Reports Q2 Loss Per Share Of EUR 0.94
Pharvaris BV reports results for the quarter ended in March - Earnings Summary
Brief: Pharvaris Reports First Quarter 2021 Financial Results And Provides Business Highlights
Pharvaris BV reports results for the quarter ended in December - Earnings Summary
Brief: Pharvaris Reports Full Year 2020 Financial Results And Provides Business Highlights
Brief: Pharvaris Reports FDA Acceptance of IND Application for Prophylactic Treatment of HAE Using PHVS416
Pharvaris N.V.: Jumps in U.S. market debut
Brief: Pharvaris N.V. Shares Open 25% Above IPO Price In Nasdaq Debut
NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 09:48 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 09:45 AM
NASDAQ RESUMED AT 09:46 AM
NASDAQ RESUMED AT 09:43 AM